Maria Rodriguez Martinez
Overview
Explore the profile of Maria Rodriguez Martinez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
1294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Castellanos-Rueda R, Wang K, Forster J, Driessen A, Frank J, Rodriguez Martinez M, et al.
Sci Adv
. 2025 Feb;
11(7):eadp4008.
PMID: 39951542
Chimeric antigen receptor (CAR) T cells offer a promising cancer treatment, yet challenges such as limited T cell persistence hinder efficacy. Given its critical role in modulating T cell responses,...
2.
Weber A, Zulcinski M, Haroon-Rashid L, Kuszlewicz B, Driessen A, Newton D, et al.
J Autoimmun
. 2025 Feb;
151:103372.
PMID: 39904264
Background: Arterial wall inflammation in giant cell arteritis (GCA) is characterized by T-cell infiltration and granuloma formation. There have been limited studies investigating the diversity of the T-cell receptor (TCR)...
3.
Niarakis A, Laubenbacher R, An G, Ilan Y, Fisher J, Flobak A, et al.
NPJ Syst Biol Appl
. 2024 Nov;
10(1):141.
PMID: 39616158
Digital twins represent a key technology for precision health. Medical digital twins consist of computational models that represent the health state of individual patients over time, enabling optimal therapeutics and...
4.
Pelissier A, Laragione T, Harris C, Rodriguez Martinez M, Gulko P
Life Sci Alliance
. 2024 Oct;
8(1).
PMID: 39467637
RNA-sequencing and differential gene expression studies have significantly advanced our understanding of pathogenic pathways underlying rheumatoid arthritis (RA). Yet, little is known about cell-specific regulatory networks and their contributions to...
5.
Driessen A, Unger S, Nguyen A, Ries R, Meshinchi S, Kreutmair S, et al.
Life Sci Alliance
. 2024 Aug;
7(11).
PMID: 39191488
Pediatric acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis and high relapse rate. Current challenges in the identification of immunotherapy targets arise from patient-specific blast...
6.
Pelissier A, Laragione T, Gulko P, Rodriguez Martinez M
Front Immunol
. 2024 Aug;
15:1428773.
PMID: 39161769
Rheumatoid arthritis (RA) is a common autoimmune and inflammatory disease characterized by inflammation and hyperplasia of the synovial tissues. RA pathogenesis involves multiple cell types, genes, transcription factors (TFs) and...
7.
Koshkin A, Herbach U, Rodriguez Martinez M, Gandrillon O, Crauste F
PLoS One
. 2024 Mar;
19(3):e0301022.
PMID: 38547073
Germinal centers (GCs) are the key histological structures of the adaptive immune system, responsible for the development and selection of B cells producing high-affinity antibodies against antigens. Due to their...
8.
Pelissier A, Laragione T, Harris C, Rodriguez Martinez M, Gulko P
bioRxiv
. 2024 Jan;
PMID: 38234777
RNA-sequencing and differential gene expression studies have significantly advanced our understanding of pathogenic pathways underlying Rheumatoid Arthritis (RA). Yet, little is known about cell-specific regulatory networks and their contributions to...
9.
Pelissier A, Laragione T, Gulko P, Rodriguez Martinez M
bioRxiv
. 2024 Jan;
PMID: 38234732
Rheumatoid arthritis (RA) is a common autoimmune and inflammatory disease characterized by inflammation and hyperplasia of the synovial tissues. RA pathogenesis involves multiple cell types, genes, transcription factors (TFs) and...
10.
Zhong Q, Sun R, Aref A, Noor Z, Anees A, Zhu Y, et al.
Life Sci Alliance
. 2023 Dec;
7(2).
PMID: 38052461
Gleason grading is an important prognostic indicator for prostate adenocarcinoma and is crucial for patient treatment decisions. However, intermediate-risk patients diagnosed in the Gleason grade group (GG) 2 and GG3...